Sma. Phillips et al., LOSS OF THE RETINOBLASTOMA SUSCEPTIBILITY GENE (RB1) IS A FREQUENT AND EARLY EVENT IN PROSTATIC TUMORIGENESIS, British Journal of Cancer, 70(6), 1994, pp. 1252-1257
Loss of the RBI gene is an important event in the initiation and progr
ession of many tumours. Prostate tissue from 43 patients with prostate
cancers and ten with benign prostatic hypertrophy (BPH) were studied
for loss of heterozygosity of the RBI gene. Four intragenic polymorphi
c loci were studied with two techniques. These were restriction fragme
nt length polymorphism (RFLP), Southern blotting and hybridisation wit
h the p123m1.8 and p68RS2.0 probes (to introns 1 and 17 respectively)
and also the polymerase chain reaction (PCR) to amplify loci within in
trons 17 and 20. Protein product (pRB) expression was determined by im
munohistochemistry using the NCL-RB antibody in nine patients with can
cer and four patients with BPH. Loss of heterozygosity was found in 24
out of 40 (60%) informative patients with cancer. Loss of RB1 occurre
d with a similar frequency in early-stage and low-grade cancers as in
more advanced cancers. Loss of RBI was also found in one patient with
BPH. Expression of pRB was completely absent from seven cancers and ma
rkedly reduced in the other two, while nuclear pRB staining was always
present in areas of BPH, whether alongside cancer-containing tissue o
r with BPH alone. We conclude that loss of RB1 is an early event in pr
ostatic tumorigenesis.